Business Context and Reporting Period
This Form 8-K Current Report was filed by Derycz Scientific, Inc. (noted as Research Solutions, Inc. in metadata) on February 14, 2011. The filing discloses the entry into a Material Definitive Agreement and the unregistered sale of equity securities.
Key Financial Metrics
- Total Capital Raised: $3,000,000
- Securities Issued: 1,200,000 shares of Common Stock and Warrants to purchase 300,000 shares.
- Unit Price: $2.50 per unit (one share + one warrant for 0.25 share).
- Warrant Terms: Exercise price of $3.00 per share; expiration three years from issuance.
- Transaction Costs: $180,000 cash fee (6% of aggregate offering) paid to placement agent T.R. Winston & Company, LLC, plus issuance of a warrant for 90,000 shares to the agent.
- Use of Proceeds: General working capital purposes.
Note: This filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity positions.
Material Changes
The primary material change is the immediate increase in outstanding equity and potential dilution resulting from the issuance of 1,200,000 new shares and warrants covering 300,000 additional shares. The filing does not provide comparative financial data to assess changes in operating performance versus prior periods.
Outlook, Risks, and Unusual Items
- Registration Rights: Investors received piggy-back registration rights subject to cut-backs, applicable only for registration statements filed within one year of issuance.
- Call Provision: The Company retains the right to call back Warrants at $0.001 per share if the Common Stock trades at or above $6.00 for ten consecutive trading days with an average daily volume exceeding 50,000 shares.
- Restrictions: The Company agreed not to undertake reverse or forward stock splits or reclassifications unless the issued shares and warrant shares are covered by an effective registration statement.
- Compliance: The offering was conducted under Section 4(2) of the Securities Act and Regulation D, relying on the exemption for sales to accredited investors without general solicitation.
Investor Verification Checklist
- Verify the exact number of shares outstanding prior to this issuance to calculate the percentage of dilution.
- Confirm the current trading price and volume of the Common Stock to assess the likelihood of the warrant call provision being triggered.
- Review the Company's most recent 10-K or 10-Q to understand the current cash position and working capital needs relative to the $3,000,000 raised.
- Check for any subsequent filings regarding the effectiveness of registration statements for the piggy-back rights.